COVID Vaccines Of China Could be Ready by November
The general population in China may start getting access to the locally prepared COVID-19 vaccines from November or December.
The general population in China may start getting access to the locally prepared COVID-19 vaccines from November or December.
‘Robust COVID-19 vaccine manufacturing, the delivery ecosystem has been initiated to meet demand.
’
Tweet it Now
With the second-highest coronavirus cases after the US, India has at least five vaccine candidates under human trial, of which three candidates are undergoing advanced Phase-2/3 clinical trials to establish safety and efficacy. In his address at an event organized by the Federation of Indian Chambers of Commerce and Industry (FICCI), Harsh Vardhan said: "We have now initiated to look at robust vaccine manufacturing and to deliver ecosystem to meet our demands in the coming days."
"As the world raises to find a cure and vaccine for Covid-19, India is looking to be self-reliant in both - vaccine and its mass production. Called as the pharmacy of the world, India has the largest capacity to produce Covid-19 vaccines," he added.
Health Experts React To Russian Covid Vaccine Cautiously
Cautiously after the news of Russia registering the world's first Covid-19 vaccine, Indian health experts stressed that it would be too early to say if it is safe or not as adequate testing didn't take place.
Cautiously after the news of Russia registering the world's first Covid-19 vaccine, Indian health experts stressed that it would be too early to say if it is safe or not as adequate testing didn't take place.
On Tuesday, Prime Minister Narendra Modi chaired a high-level meeting in which the modalities of Covid-19 vaccine delivery, distribution, and administration were discussed. He reassured that the government is keeping watch on developments.
Advertisement
Moderna Announces 94.5 Percent Effectiveness in COVID Vaccine
US pharma giant Moderna's COVID vaccine candidate has shown more than 94.5 percent effectiveness in preliminary data from its ongoing study.
US pharma giant Moderna's COVID vaccine candidate has shown more than 94.5 percent effectiveness in preliminary data from its ongoing study.
Bovine Adenovirus Used to Develop COVID Vaccine
Indian-origin research team in the US is developing a unique Covid-19 vaccine that uses a bovine adenovirus that will protect all population segments, especially older adults.
Indian-origin research team in the US is developing a unique Covid-19 vaccine that uses a bovine adenovirus that will protect all population segments, especially older adults.
